NCT07722052

Brief Summary

The objective of our study was to evaluate the incidence of hemidiaphragmatic paralysis after ultrasound-guided stellate ganglion block (US-SGB) by assessing diaphragmatic excursion and diaphragmatic thickening fraction using diaphragm ultrasound.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 10, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

July 15, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 23, 2026

Completed
Last Updated

July 23, 2026

Status Verified

July 1, 2026

Enrollment Period

1 year

First QC Date

July 15, 2026

Last Update Submit

July 22, 2026

Conditions

Keywords

stellate ganglion blockdiaphragm ultrasoundhemidiaphragmatic paralysisdiaphragmatic excursiondiaphragmatic thickening fractionspirometry

Outcome Measures

Primary Outcomes (2)

  • Diaphragmatic excursion

    Excursion of the diaphragmatic dome was assessed by a pulmonologist experienced in diaphragm ultrasound assessment. Once the dome was identified, excursion was measured in M-mode as the distance, in centimeters, between the end-expiratory and end-inspiratory positions during a vital capacity manoeuvre.

    The diaphragmatic excursion, assessed by diaphragm ultrasound before and 30 minutes after US-SGB.

  • Diaphragmatic thickening fraction

    The diaphragmatic thickening fraction was assessed by a pulmonologist experienced in diaphragm ultrasound assessment. Diaphragm thickness was measured, in centimeters, at end-inspiration and end-expiration during a vital capacity manoeuvre. Thickening fraction was calculated using the following formula and expressed as a percentaje: Thickening fraction = \[(thickness at end-inspiration - thickness at end-expiration) / thickness at end-expiration\] x 100.

    The diaphragmatic thickening, assessed by diaphragm ultrasound before and 30 minutes after US-SGB.

Secondary Outcomes (4)

  • Forced vital capacity (FVC)

    Spirometric parameters measured at baseline and 1 hour after US-SGB.

  • Forced expiratory volume in 1 second (FEV1)

    Spirometric parameters measured at baseline and 1 hour after US-SGB.

  • Tiffeneau index (FEV1/FVC ratio)

    Spirometric parameters measured at baseline and 1 hour after US-SGB.

  • Peripheral oxygen saturation (SpO2)

    Measured at baseline and 1 hour after US-SGB.

Study Arms (1)

US-SGB

Patients with sympathetic nervous system-mediated disorders of the upper limb undergoing a first diagnostic ultrasound-guided stellate ganglion block (US-SGB).

Procedure: Ultrasound-guided stellate ganglion block

Interventions

US-SGB was performed at the C7 level using 10 ml of 0.25% levobupivacaíne.

US-SGB

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

After approval of the study by the Principality of Asturias Drug Research Ethics Committee (CEImPA), Spain, and obtaining informed consent from the participants, all consecutive patients undergoing a first diagnostic US-SGB for sympathetic nervous system-mediated disorders were prospectively included.

You may qualify if:

  • patients over 18 years of age.
  • patients with sympathetic nervous system-mediated disorders.

You may not qualify if:

  • patients younger than 18 years of age.
  • patients with severe chronic obstructive pulmonary disease.
  • previous diaphragmatic paralysis or neuromuscular disease.
  • inability to undergo diaphragmatic ultrasound.
  • patients with neck anatomy considered unsuitable for the procedure (including previous neck surgery, burns, extensive scarring or large goiters resulting in distortion of normal cervical anatomy).
  • contraindications to the interventional technique (such as infection at the puncture site, or refusal to provide consent).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

FINBA

Oviedo, Principality of Asturias, 33001, Spain

Location

Related Publications (6)

  • Rafla C, Zitek T, Shalaby M. A systematic review of the respiratory effects of ultrasound-guided phrenic nerve block. Anesth Pain Med (Seoul). 2025 Oct;20(4):371-383. doi: 10.17085/apm.25214. Epub 2025 Sep 26.

  • Santana PV, Cardenas LZ, Albuquerque ALP, Carvalho CRR, Caruso P. Diaphragmatic ultrasound: a review of its methodological aspects and clinical uses. J Bras Pneumol. 2020 Nov 20;46(6):e20200064. doi: 10.36416/1806-3756/e20200064. eCollection 2020.

  • Sferrazza Papa GF, Pellegrino GM, Di Marco F, Imeri G, Brochard L, Goligher E, Centanni S. A Review of the Ultrasound Assessment of Diaphragmatic Function in Clinical Practice. Respiration. 2016;91(5):403-11. doi: 10.1159/000446518. Epub 2016 May 25.

  • Tsai EH, Nunez-Rodriguez E, Cata JP. Stellate ganglion block in perioperative practice: a narrative review. Br J Anaesth. 2026 Jan;136(1):179-196. doi: 10.1016/j.bja.2025.07.095. Epub 2025 Sep 29.

  • Motazedian P, Quinn N, Wells GA, Beauregard N, Lam E, Mathieu ME, Knoll W, Prosperi-Porta G, Ly V, Parlow S, Di Santo P, Abdel-Razek O, Jung R, Simard T, Jentzer JC, Mathew R, Ramirez FD, Hibbert B. Efficacy of stellate ganglion block in treatment of electrical storm: a systematic review and meta-analysis. Sci Rep. 2024 Oct 21;14(1):24719. doi: 10.1038/s41598-024-76663-9.

  • Kirkpatrick K, Khan MH, Deng Y, Shah KB. A Review of Stellate Ganglion Block as an Adjunctive Treatment Modality. Cureus. 2023 Feb 19;15(2):e35174. doi: 10.7759/cureus.35174. eCollection 2023 Feb.

Study Officials

  • Daniel García Iglesias, MD, PhD

    Central University Hospital of Asturias, 33001, Spain

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
MD. Consultant Anesthesiologist and Pain Physician

Study Record Dates

First Submitted

July 15, 2026

First Posted

July 23, 2026

Study Start

December 1, 2024

Primary Completion

December 10, 2025

Study Completion

June 1, 2026

Last Updated

July 23, 2026

Record last verified: 2026-07

Locations